Koers Sartorius Aktiengesellschaft Other OTC
Aandelen
SUVPF
DE0007165631
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 3,57 mld. 3,87 mld. | Omzet 2025 * | 4 mld. 4,34 mld. | Marktkapitalisatie | 16,76 mld. 18,19 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 218 mln. 237 mln. | Nettowinst (verlies) 2025 * | 355 mln. 385 mln. | EV/omzet 2024 * | 5,83 x |
Nettoschuld 2024 * | 4,05 mld. 4,4 mld. | Nettoschuld 2025 * | 3,82 mld. 4,14 mld. | EV/omzet 2025 * | 5,14 x |
K/w-verhouding 2024 * |
74
x | K/w-verhouding 2025 * |
51,1
x | Werknemers | - |
Dividendrendement 2024 * |
0,31% | Dividendrendement 2025 * |
0,41% | Vrij verhandelbaar | 35,03% |
Recentste transcriptie over Sartorius Aktiengesellschaft
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 59 | 01-05-99 | |
Chief Tech/Sci/R&D Officer | 59 | 01-01-95 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 01-01-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 01-01-20 |
Director/Board Member | 75 | 29-11-11 | |
Director/Board Member | 58 | 06-04-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-43,89% | 2,77 mld. | |
+23,49% | 1,96 mld. | |
-3,70% | 1,61 mld. | |
+31,41% | 1,31 mld. | |
-16,85% | 960 mln. | |
-23,12% | 881 mln. | |
+3,17% | 809 mln. | |
+24,76% | 590 mln. | |
-.--% | 483 mln. |